Screener
Ligand Pharmaceuticals LGND Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's free cash flow margin?
- Ligand Pharmaceuticals (LGND) reported free cash flow margin of 45.2% in Q2 2026.
- How has Ligand Pharmaceuticals's free cash flow margin changed year-over-year?
- Ligand Pharmaceuticals's free cash flow margin increased by 58.3% year-over-year, from 28.6% to 45.2%.
- What is the long-term trend for Ligand Pharmaceuticals's free cash flow margin?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's free cash flow margin has grown at a -7.9% compound annual growth rate (CAGR), from 27.5% to 18.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Ligand Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude